Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA

Journal of Rheumatology

Volumn 36, Issue 12, 2009, Pages 2704-2710

  Antiochos, Brendan B ^a   Brown, Lin A ^b   Li, Zhongze ^c   Tosteson, Tor D ^b   Wortmann, Robert L ^b   Rigby, William F C ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH COLLEGE   (United States)

Author keywords

Dermatomyositis; Malignancy; Polymyositis

Indexed keywords

ANTINUCLEAR ANTIBODY; CREATINE KINASE; DNA ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BLADDER CARCINOMA; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COLON CANCER; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; FEMALE; HISTOLOGY; HUMAN; IDIOPATHIC DISEASE; INCLUSION BODY MYOSITIS; INFLAMMATORY DISEASE; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERSTITIAL LUNG DISEASE; LABORATORY TEST; LARYNX CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MYOPATHY; OVARY CARCINOMA; PANCREAS CANCER; PAROTID GLAND CARCINOMA; POLYMYOSITIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; DERMATOMYOSITIS; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; NEOPLASMS; NEW ENGLAND; POLYMYOSITIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 72449131057     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090549     Document Type: Article

References (34)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis (parts 1 and 2). N Engl J Med 1975;292:344-7, 403-407
2. Carpenter S, Karpati G, Heller I, Eisen A. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 1978;28:8-17. (Pubitemid 8272513)
3. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: a review. J Invest Dermatol 1993;100:124S-127S.
4. Stertz G. Polymyositis. Berl Klin Wochenschr 1916;53:489.
5. Lakhanpal S, Bunch TW, Ilstrup DM, Melton LJ 3rd. Polymyositis- dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc 1986;61:645-653
6. Lyon MG, Bloch DA, Hollak B, Fries JF. Predisposing factors in polymyositis-dermatomyositis: results of a nationwide survey. J Rheumatol 1989;16:1218-1224 (Pubitemid 19260111)
7. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001;134:1087-1095
8. Chow WH, Gridley G, Mellemkjaer L, McLaughlin JK, Olsen JH, Fraumeni JF Jr. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 1995;6:9-13.
9. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001;357:96-100. (Pubitemid 32094911)
10. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992;326:363-367
11. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001;85:41-45 (Pubitemid 32695714)
12. Zantos D, Zhang Y, Felson D. The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 1994;21:1855-1859 (Pubitemid 24312647)
13. Airio A, Pukkala E, Isomäki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 1995;22:1300-1303
14. Andras C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 2008;35:438-444
15. Callen JP, Hyla JF, Bole GG Jr, Kay DR. The relationship of dermatomyositis and polymyositis to internal malignancy. Arch Dermatol 1980;116:295-298
16. Holden DJ, Brownell AK, Fritzler MJ. Clinical and serologic features of patients with polymyositis or dermatomyositis. Can Med Assoc J 1985;132:649-653 (Pubitemid 15107146)
17. Wakata N, Kurihara T, Saito E, Kinoshita M. Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 2002;41:729-734 (Pubitemid 35422835)
18. Ang P, Sugeng MW, Chua SH. Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy. Ann Acad Med Singapore 2000;29:219-223
19. Fung WK, Chan HL, Lam WM. Amyopathic dermatomyositis in Hong Kong - association with nasopharyngeal carcinoma. Int J Dermatol 1998;37:659-663
20. Sherry DD, Haas JE, Milstein JM. Childhood polymyositis as a paraneoplastic phenomenon. Pediatr Neurol 1993;9:155-156
21. Whitmore SE, Watson R, Rosenshein NB, Provost TT. Dermatomyositis sine myositis: association with malignancy. J Rheumatol 1996;23:101-105 (Pubitemid 26036003)
22. Cancer Registry Public Information Data: 1999-2002, WONDER On-line Database. U.S. Department of Health and Human Services, National Program of Cancer Registries, Centers for Disease Control and Prevention. November 2005. Available at: http://wonder.cdc.gov/cancer-v2002.html. Accessed September 24, 2009.
23. Sahai H, Khurshid A. Confidence intervals for the mean of a Poisson distribution: a review. Biometrical J 1993;35:857-867
24. Barnes BE, Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 1976;84:68-76.
25. Basset-Seguin N, Roujeau JC, Gherardi R, Guillaume JC, Revuz J, Touraine R. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases. Arch Dermatol 1990;126:633-637
26. Bonnetblanc JM, Bernard P, Fayol J. Dermatomyositis and malignancy. A multicenter cooperative study. Dermatologica 1990;180:212-216
27. Manchul LA, Jin A, Pritchard KI, Tenenbaum J, Boyd NF, Lee P, et al. The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study. Arch Intern Med 1985;145:1835-1839
28. Maoz CR, Langevitz P, Livneh A, Blumstein Z, Sadeh M, Bank I, et al. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum 1998;27:319-324 (Pubitemid 28176237)
29. van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, et al. Polymyositis: an overdiagnosed entity. Neurology 2003;61:316-321
30. Amato AA, Griggs RC. Unicorns, dragons, polymyositis, and other mythological beasts. Neurology 2003;61:288-289
31. Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol 2001;144:825-831
32. Leow YH, Goh CL. Malignancy in adult dermatomyositis. Int J Dermatol 1997;36:904-907
33. Oddis CV, Conte CG, Steen VD, Medsger TA Jr. Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990;17:1329-1334
34. Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 2007;66:1345-1349 (Pubitemid 47492479)